Clinical Trial
Phase II Adaptive Deep Brain Stimulation for Obsessive-Compulsive Disorder
ClinicalTrials.gov4/1/2021·04/01/21🌐 USA
Summary
This study at Baylor College of Medicine uses the Summit RC+S responsive neurostimulator with ECoG paddle electrodes for adaptive closed-loop DBS in treatment-resistant OCD. Unlike conventional open-loop DBS, this system records brain activity and automatically adjusts stimulation delivery based on neural biomarkers.
Why it matters
Adaptive closed-loop DBS represents the next generation of neuromodulation technology, moving from fixed stimulation to personalized, brain-state-responsive therapy. For OCD, this could demonstrate that biomarker-driven stimulation is more effective than conventional DBS.
#Deep Brain Stimulation#OCD#Closed-Loop#Neurostimulation#Phase 2#USA#Neurodiagnostics
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in